Summary & Overview
HCPCS A6023: Collagen Dressing, Sterile, >48 sq. in.
HCPCS Level II code A6023 denotes a sterile collagen dressing larger than 48 square inches, used as an advanced wound care supply to support tissue repair. Nationally, this code is relevant for facilities and clinicians managing complex or large wounds where biologic dressings are indicated. Use of large collagen dressings affects supply cost, documentation, and billing workflows across outpatient, home health, and long-term care settings.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and typical sites of service, benchmarks for utilization and reimbursement ranges where available, and clinical context explaining when a large collagen dressing is typically applied. The publication outlines common billing modifiers and administrative factors that affect claim adjudication, and it flags areas where payers often require supporting documentation such as wound measurements, wound etiology, and evidence of prior standard wound care.
This summary is intended for billing managers, clinicians involved in wound care, and policy analysts seeking a concise national perspective on coding, coverage issues, and administrative considerations for HCPCS Level II code A6023.
Billing Code Overview
HCPCS Level II code A6023 describes a collagen dressing, sterile, size more than 48 sq. in., each. This item is a biologic wound dressing composed primarily of collagen, intended to support wound healing through a sterile, absorbable matrix applied directly to the wound surface.
Service type: Wound care supply — advanced biologic dressing
Typical site of service: Outpatient wound care clinics, hospital outpatient departments, long-term care facilities, and home health settings where advanced dressings are applied by clinicians or trained caregivers.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old with a chronic non-healing lower extremity wound after venous stasis ulcer debridement. The wound measures 60 square inches after surgical debridement. The clinician applies a sterile collagen dressing sized more than 48 square inches (A6023) to provide a biologic scaffold that supports granulation and cellular migration. The procedure is performed in an outpatient wound care clinic or ambulatory surgery center. The clinical workflow includes wound assessment, measurement, cleansing and debridement as indicated, application of the sterile collagen dressing to cover the wound bed, fixation with appropriate secondary dressings, documentation of wound size and appearance, and scheduling follow-up visits for dressing changes and reassessment. The typical site of service is an outpatient wound care clinic, physician office, or ambulatory surgical center when the dressing is applied as part of wound management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No Modifier | When no specific modifier applies to the service. |
26 | Professional Component |